Literature DB >> 28705773

Recent progress in circular RNAs in human cancers.

Guanqun Huang1, Shuaihu Li1, Nuo Yang2, Yongdong Zou3, Duo Zheng4, Tian Xiao5.   

Abstract

Circular RNAs (circRNAs) are a large class of endogenous RNAs, formed by exon skipping or back-splicing events as covalently closed loops, which are expressed abundantly in mammalian cells. Although their biological functions remain largely unknown, recent studies show that circRNAs have three main functions in mammalian cells. First, circRNAs can regulate transcription and RNA splicing. Second, circRNAs function as microRNA (miRNA) sponges. Third, they can be translated into protein driven by N6-methyladenosine modification. Taking advantage of RNA sequencing (RNA-seq) technology, the expressions of circRNAs were found to be dysregulated in all types of cancer cell lines, tumor tissues, and even plasma samples from patients, which correlated with certain clinical characteristics, suggesting the potential roles of circRNAs in tumor progression. Considering their conserved sequences and stable structures, circRNAs were deemed to be promising biomarkers for the early diagnosis and prognosis prediction of cancer. In this review, we describe briefly the formation and properties of circRNAs, and focus mainly on recent progress in research into their function, regulation, and clinical relevance in different cancers.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer biomarkers; Circular RNAs; MicroRNA sponge; Transcription regulation; m(6)A-driven translation

Mesh:

Substances:

Year:  2017        PMID: 28705773     DOI: 10.1016/j.canlet.2017.07.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  34 in total

1.  Research progress on circularRNAs in pancreatic cancer: emerging but promising.

Authors:  Yi-Zhi Wang; Yang An; Bing-Qi Li; Jun Lu; Jun-Chao Guo
Journal:  Cancer Biol Ther       Date:  2019-05-28       Impact factor: 4.742

2.  Analysis of co-expression networks for circular RNAs and mRNAs reveals that circular RNAs hsa_circ_0047905, hsa_circ_0138960 and has-circRNA7690-15 are candidate oncogenes in gastric cancer.

Authors:  Zhiyong Lai; Yang Yang; Yichao Yan; Tao Li; Yansen Li; Zhu Wang; Zhanlong Shen; Yingjiang Ye; Kewei Jiang; Shan Wang
Journal:  Cell Cycle       Date:  2017-11-09       Impact factor: 4.534

Review 3.  Circular RNAs: Functions and Prospects in Glioma.

Authors:  Zheng Hao; Si Hu; Zheng Liu; Weixin Song; Yeyu Zhao; Meihua Li
Journal:  J Mol Neurosci       Date:  2018-11-20       Impact factor: 3.444

4.  A microarray expression profile and bioinformatic analysis of circular RNA in human esophageal carcinoma.

Authors:  Sina Cai; Yuqin Zhang; Xiaona Zhang; Liping Wang; Ziqing Wu; Weiyi Fang; Xiaohua Chen
Journal:  J Gastrointest Oncol       Date:  2022-04

5.  Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.

Authors:  Jinhua Zhang; Gottumakkala S Raju; David W Chang; Shu-Hong Lin; Zhinan Chen; Xifeng Wu
Journal:  Cancer       Date:  2017-11-07       Impact factor: 6.860

6.  The Use of circRNAs as Biomarkers of Cancer.

Authors:  Carla Solé; Gartze Mentxaka; Charles H Lawrie
Journal:  Methods Mol Biol       Date:  2021

Review 7.  Circular RNAs: a new frontier for cancer diagnosis and therapy.

Authors:  Miaoci Zhang; Yan Xin
Journal:  J Hematol Oncol       Date:  2018-02-13       Impact factor: 17.388

8.  hsa_circ_0058092 protects against hyperglycemia‑induced endothelial progenitor cell damage via miR‑217/FOXO3.

Authors:  Jie Cheng; Weiwei Hu; Fenghui Zheng; Yongfa Wu; Maoquan Li
Journal:  Int J Mol Med       Date:  2020-06-29       Impact factor: 4.101

9.  CircPSMC3 Suppresses Migration and Invasion of Non-Small Cell Lung Cancer Cells via miR-182-5p/NME2 Axis.

Authors:  Tao Xu; Yejun Yu; Shengcong Guo; Lixiang He; Zejun Mao
Journal:  Med Sci Monit       Date:  2020-05-09

Review 10.  [Research Progress of Circular RNA in Lung Cancer].

Authors:  Yinyu Mu; Fuyi Xie
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.